Tumor immune microenvironment in non-small cell lung cancer progression - Top-Institutions - MDSpire

Tumor immune microenvironment in non-small cell lung cancer progression

  • By

  • Jie Jiang

  • Mingqiang Zhong

  • Jian Wang

  • Zhiya Zhang

  • Wenqiang Li

  • Zhiping Deng

  • May 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #3

    Columbia University Medical Center
    Columbia University Medical Center

    New York, New York

    Key Differentiators

    • Oncology

  • #4

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Oncology

  • #5

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Oncology

Original Source(s)

Tumor immune microenvironment in non-small cell lung cancer progression

  • by Jie Jiang, Mingqiang Zhong, Jian Wang, Zhiya Zhang, Wenqiang Li, Zhiping Deng

  • May 18, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate